PENICILLIN G POTASSIUM FOR INJECTION, USP DIN 02220245
Status: Cancelled Post Market
Holder: PHARMACEUTICAL PARTNERS OF CANADA INC
Molecule: PENICILLIN G (PENICILLIN G POTASSIUM)
Health Canada record
| Active ingredient(s) | PENICILLIN G (PENICILLIN G POTASSIUM) 5000000 UNIT |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CE01 BENZYLPENICILLIN |
| Original market date | 04-May-1998 |
| Current status date | 10-Jan-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmaceutics International Inc. — licence , not currently licensed, last inspection rating I (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PENICILLIN G (PENICILLIN G POTASSIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02220237 | PENICILLIN G POTASSIUM FOR INJECTION, USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | PENICILLIN G (PENICILLIN G POTASSIUM) 1000000 UNIT | Cancelled Post Market |
| 02220253 | PENICILLIN G POTASSIUM FOR INJECTION, USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | PENICILLIN G (PENICILLIN G POTASSIUM) 10000000 UNIT | Cancelled Post Market |